Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis

NCT02778919 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: KLH-2109
DRUG: Placebo
DRUG: Leuprorelin acetate

Sponsor

Kissei Pharmaceutical Co., Ltd.